查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1584131

免疫毒素市场，按类型、交付方式、目标适应症、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Immunotoxins Market, By Type, By Delivery Method, By Target Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年免疫毒素市场规模为1.429亿美元，2024年至2032年复合年增长率为8.90%。

免疫毒素市场-市场动态

增加对研究和战略合作伙伴关係的投资推动薄膜电容器市场的创新

对研究和战略合作伙伴关係的不断增加的投资极大地推动了免疫毒素市场的创新，安进（Amgen）和基因泰克（Genentech）等主要製药公司每年拨款数十亿美元来开发靶向癌症疗法。据美国国家癌症研究所称，2021 年美国新诊断出约 190 万癌症病例，凸显了创新治疗的迫切需求。阿斯特捷利康和默克之间合作推进抗体药物偶联物技术对于提高治疗效果至关重要。此外，欧盟的「地平线 2020」计划资助了许多专注于免疫毒素的研究计划，进一步巩固了该行业的成长。随着这些合作的不断蓬勃发展，预计将导致新型免疫毒素的开发，从而改善患者的治疗效果并扩大治疗选择。

免疫毒素市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.90% 左右的复合年增长率成长

根据类型细分，预计单株抗体免疫毒素将在 2023 年显示出最大的市场份额

根据给药方法细分，系统给药是 2023 年的主导类型

根据目标适应症细分，血液系统恶性肿瘤是2023年的主导类型

按地区划分，北美是 2023 年的主要收入来源

免疫毒素市场-細項分析：

全球免疫毒素市场根据类型、递送方法、目标适应症、最终用户和区域进行细分。

市场根据类型分为三类：重组免疫毒素、嵌合抗原受体 (CAR) T 细胞疗法和单株抗体免疫毒素。基于单株抗体的免疫毒素因其在标靶治疗中的既定功效而占据最高的市场份额，其次是重组免疫毒素，它提供了创新的治疗选择。嵌合抗原受体（CAR）T细胞疗法排名第三，显示出巨大的潜力。

根据交付方式，市场分为两类：系统管理和本地管理。全身给药因其能够有效治疗广泛的癌症而被优先考虑，而局部给药则紧随其后，提供副作用较少的标靶治疗。两种方法都能满足不同的治疗需求和患者状况，进而增强治疗选择。

免疫毒素市场 - 地理洞察

免疫毒素市场的地理模式揭示了北美、欧洲和亚太地区的重要活动，每个活动都对市场动态做出了独特的贡献。北美，尤其是美国，由于先进的医疗基础设施、高额研发投资以及安进和基因泰克等大型製药公司的存在，在市场份额方面处于领先地位。美国国家癌症研究所强调了一系列强大的免疫毒素疗法，显示该地区正在进行临床试验和创新。欧洲也是一个关键参与者，受到对先进疗法的监管支持和对精准医疗日益重视的推动，德国和英国等国家取得了显着的发展。同时，在癌症盛行率上升和医疗保健普及的推动下，亚太地区正在成为一个充满前景的市场，特别是在中国和印度等国家，这些国家的政府正在投资生物技术研究。本地公司和国际公司之间的合作进一步增强了该地区的市场潜力，为全球免疫毒素疗法的进步做出了贡献。

免疫毒素市场-竞争格局：

免疫毒素市场竞争格局的特点是成熟的製药公司和创新的生物技术公司混合在一起，所有这些公司都透过研究、开发和策略合作来争夺市场份额。安进（Amgen）、基因泰克（Genentech）和礼来（Eli Lilly）等主要参与者利用其在肿瘤学方面的丰富资源和专业知识，积极参与免疫毒素疗法的开发和商业化。例如，安进公司 FDA 批准的免疫毒素 blinatumomab (Blincyto) 为治疗某些类型的白血病设定了基准，说明了这种治疗方法的潜力。新兴的参与者，如ImmunoGen和StemSynergy Therapeutics，也在利用独特的免疫毒素候选物和新颖的递送机制方面取得了长足的进步，从而促进了创新和竞争压力。合作在这个市场上很常见；例如，生物技术公司和学术机构之间的伙伴关係正在推动研究工作，从而开展探索免疫毒素新应用和组合的临床试验。这种充满活力的环境得到了生物技术研究增加投资和对个人化医疗的重视的进一步支持，从而使免疫毒素市场实现持续成长和进步。

最新进展：

2024 年 4 月，Invera Inc. 和 Astellas Pharma 宣布合作开发治疗性双特异性抗体。安斯泰来製药公司将利用 Invera 的 B-Body 双特异性抗体平台来推进其双特异性治疗应用的研究。

2023 年1 月，List Biological Labs, Inc. 透过整合新型500L 生物反应器和切向流过滤系统，增强了其细菌治疗药物的製造能力，旨在提高生产效率并满足对细菌治疗药物不断增长的需求。

目录

第一章：免疫毒素市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的免疫毒素市场片段
    • 按交付方式分類的免疫毒素市场片段
    • 按目标指示分類的免疫毒素市场片段
    • 最终用户的免疫毒素市场片段
    • 按国家/地区分類的免疫毒素市场片段
    • 按地区分類的免疫毒素市场片段
  • 竞争洞察

第 3 章：免疫毒素主要市场趋势

  • 免疫毒素市场驱动因素
    • 市场驱动因素的影响分析
  • 免疫毒素市场限制
    • 市场限制影响分析
  • 免疫毒素市场机会
  • 免疫毒素市场未来趋势

第 4 章：免疫毒素产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：免疫毒素市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：免疫毒素市场格局

  • 2023 年免疫毒素市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：免疫毒素市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 重组免疫毒素
    • 嵌合抗原受体 (CAR) T 细胞疗法
    • 基于单株抗体的免疫毒素

第 8 章：免疫毒素市场 - 按交付方式

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 全身给药
    • 地方政府

第 9 章：免疫毒素市场 - 依目标指示

  • 概述
    • 按目标指示分類的细分市场占有率分析
    • 实体肿瘤
    • 血液系统恶性肿瘤
    • 自体免疫疾病

第 10 章：免疫毒素市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 癌症研究机构
    • 专科诊所

第 11 章：免疫毒素市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美免疫毒素主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按交付方式）
    • 北美市场规模和预测（按目标指示）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲免疫毒素主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按交付方式）
    • 欧洲市场规模和预测（按目标指示）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区免疫毒素主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（以交付方式）
    • 亚太地区市场规模与预测（依目标指示）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲免疫毒素主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模和预测（以交付方式）
    • 拉丁美洲市场规模和预测（按目标指示）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲免疫毒素主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（以交付方式）
    • 中东和非洲市场规模及预测（依目标指示）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 免疫毒素产业

  • 竞争仪表板
  • 公司简介
    • Amgen Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Daiichi Sankyo Company, Limited
    • Eisai Co., Ltd.
    • Eli Lilly and Company
    • Genentech, Inc.
    • Immunomedics, Inc. (Gilead Sciences)
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Roche Holding AG
    • Sanofi SA
    • Seattle Genetics, Inc.
    • Takeda Pharmaceutical Company Limited
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4093

REPORT HIGHLIGHT

Immunotoxins Market size was valued at USD 142.90 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.

The Immunotoxins market, which focuses on targeted therapies combining antibodies with cytotoxic agents to selectively kill cancer cells, is gaining momentum due to the increasing prevalence of cancer and autoimmune diseases. With an estimated 1.9 million new cancer cases expected in the U.S. alone in 2024, the demand for effective treatments is on the rise. This growing need is spurred by advancements in biotechnology, leading to the development of more effective immunotoxin formulations that enhance therapeutic efficacy while minimizing side effects. However, challenges such as high production costs and stringent regulatory approvals can hinder market growth. Moreover, the complexity of immunotoxin mechanisms can lead to variability in patient responses, raising concerns about treatment consistency. Nevertheless, the expanding research pipeline and the exploration of combination therapies present significant opportunities for market expansion. Companies are increasingly investing in clinical trials and strategic collaborations to innovate and diversify their product offerings, positioning themselves to meet the evolving needs of patients and healthcare providers in the oncology landscape.

Immunotoxins Market- Market Dynamics

Increasing Investment in Research and Strategic Partnerships Fuels Innovation in the Film Capacitor Market

The increasing investment in research and strategic partnerships is significantly driving innovation in the immunotoxins market, with major pharmaceutical companies like Amgen and Genentech allocating billions annually to develop targeted cancer therapies. According to the National Cancer Institute, approximately 1.9 million new cancer cases were diagnosed in the U.S. in 2021, underscoring the urgent need for innovative treatments. Collaborations such as the partnership between AstraZeneca and Merck to advance antibody-drug conjugate technology are pivotal in enhancing therapeutic efficacy. Moreover, the European Union's Horizon 2020 program has funded numerous research initiatives focusing on immunotoxins, further solidifying the sector's growth. As these collaborations continue to flourish, they are expected to lead to the development of novel immunotoxins that improve patient outcomes and expand treatment options.

Immunotoxins Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)

Based on Type segmentation, Monoclonal Antibody-Based Immunotoxins were predicted to show maximum market share in the year 2023

Based on Delivery Method segmentation, Systemic Administration was the leading type in 2023

Based on Target Indication segmentation, Hematologic Malignancies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Immunotoxins Market- Segmentation Analysis:

The Global Immunotoxins Market is segmented on the basis of Type, Delivery Method, Target Indication, End-User, and Region.

The market is divided into three categories based on Type: Recombinant Immunotoxins, Chimeric Antigen Receptor (CAR) T-cell therapy, and Monoclonal Antibody-Based Immunotoxins. Monoclonal Antibody-Based Immunotoxins hold the highest market share due to their established efficacy in targeted therapies, followed by Recombinant Immunotoxins, which offer innovative treatment options. Chimeric Antigen Receptor (CAR) T-cell therapy ranks third, showcasing significant potential.

The market is divided into two categories based on the Delivery Method: Systemic Administration and Local Administration. Systemic Administration is prioritized due to its ability to treat widespread cancers effectively, while Local Administration follows, offering targeted treatment with fewer side effects. Both methods cater to different therapeutic needs and patient profiles, enhancing treatment options.

Immunotoxins Market- Geographical Insights

The geographical landscape of the Immunotoxins market reveals significant activity across North America, Europe, and Asia-Pacific, each contributing uniquely to market dynamics. North America, particularly the United States, leads in market share due to advanced healthcare infrastructure, high investment in research and development, and the presence of major pharmaceutical companies like Amgen and Genentech. The National Cancer Institute has highlighted a robust pipeline of immunotoxin therapies, indicating ongoing clinical trials and innovations in this region. Europe is also a key player, driven by regulatory support for advanced therapies and a growing emphasis on precision medicine, with notable developments in countries like Germany and the UK. Meanwhile, the Asia-Pacific region is emerging as a promising market, fueled by increasing cancer prevalence and expanding healthcare access, particularly in countries like China and India, where governments are investing in biotechnology research. Collaborative efforts between local firms and international companies further enhance the market potential in this region, contributing to the global advancement of immunotoxin therapies.

Immunotoxins Market- Competitive Landscape:

The competitive landscape of the Immunotoxins market is characterized by a mix of established pharmaceutical companies and innovative biotech firms, all vying for market share through research, development, and strategic collaborations. Major players such as Amgen, Genentech, and Eli Lilly are actively involved in developing and commercializing immunotoxin therapies, leveraging their extensive resources and expertise in oncology. For instance, Amgen's FDA-approved immunotoxin, blinatumomab (Blincyto), has set a benchmark in treating certain types of leukemia, illustrating the potential of this therapeutic approach. Emerging players, like ImmunoGen and StemSynergy Therapeutics, are also making strides with unique immunotoxin candidates and novel delivery mechanisms, fostering innovation and competitive pressure. Collaborations are common in this market; for example, partnerships between biotech firms and academic institutions are driving research efforts, leading to clinical trials that explore new applications and combinations of immunotoxins. This dynamic environment is further supported by increasing investments in biotechnology research and an emphasis on personalized medicine, positioning the Immunotoxins market for continued growth and advancement.

Recent Developments:

In April 2024, Invera Inc. and Astellas Pharma announced a collaboration to develop therapeutic bispecific antibodies. Astellas Pharma will utilize Invera's B-Body bispecific antibody platform to advance its research in bispecific therapeutic applications.

In January 2023, List Biological Labs, Inc. enhanced its bacterial therapeutic manufacturing capabilities by incorporating a new 500L bioreactor along with a tangential flow filtration system, aimed at increasing production efficiency and meeting growing demand for bacterial therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOTOXINS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Daiichi Sankyo Company, Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Genentech, Inc.
  • Immunomedics, Inc. (Gilead Sciences)
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Others

GLOBAL IMMUNOTOXINS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Recombinant Immunotoxins
  • Chimeric Antigen Receptor (CAR) T-Cell Therapy
  • Monoclonal Antibody-Based Immunotoxins

GLOBAL IMMUNOTOXINS MARKET, BY DELIVERY METHOD- MARKET ANALYSIS, 2019 - 2032

  • Systemic Administration
  • Local Administration

GLOBAL IMMUNOTOXINS MARKET, BY TARGET INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Solid Tumors
  • Hematological Malignancies
  • Autoimmune Diseases

GLOBAL IMMUNOTOXINS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Cancer Research Institutes
  • Specialty Clinics

GLOBAL IMMUNOTOXINS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunotoxins Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunotoxins Market Snippet by Type
    • 2.1.2. Immunotoxins Market Snippet by Delivery Method
    • 2.1.3. Immunotoxins Market Snippet by Target Indication
    • 2.1.4. Immunotoxins Market Snippet by End-User
    • 2.1.5. Immunotoxins Market Snippet by Country
    • 2.1.6. Immunotoxins Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunotoxins Key Market Trends

  • 3.1. Immunotoxins Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunotoxins Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunotoxins Market Opportunities
  • 3.4. Immunotoxins Market Future Trends

4. Immunotoxins Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunotoxins Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunotoxins Market Landscape

  • 6.1. Immunotoxins Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunotoxins Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Recombinant Immunotoxins
    • 7.1.3. Chimeric Antigen Receptor (CAR) T-Cell Therapy
    • 7.1.4. Monoclonal Antibody-Based Immunotoxins

8. Immunotoxins Market - By Delivery Method

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Method, 2023 & 2032 (%)
    • 8.1.2. Systemic Administration
    • 8.1.3. Local Administration

9. Immunotoxins Market - By Target Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Target Indication, 2023 & 2032 (%)
    • 9.1.2. Solid Tumors
    • 9.1.3. Hematological Malignancies
    • 9.1.4. Autoimmune Diseases

10. Immunotoxins Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Cancer Research Institutes
    • 10.1.4. Specialty Clinics

11. Immunotoxins Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Immunotoxins Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Immunotoxins Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Immunotoxins Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Immunotoxins Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Immunotoxins Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Delivery Method, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Target Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Immunotoxins Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Amgen Inc.
    • 12.2.2. AstraZeneca PLC
    • 12.2.3. Bayer AG
    • 12.2.4. Daiichi Sankyo Company, Limited
    • 12.2.5. Eisai Co., Ltd.
    • 12.2.6. Eli Lilly and Company
    • 12.2.7. Genentech, Inc.
    • 12.2.8. Immunomedics, Inc. (Gilead Sciences)
    • 12.2.9. Johnson & Johnson
    • 12.2.10. Merck & Co., Inc.
    • 12.2.11. Novartis AG
    • 12.2.12. Pfizer Inc.
    • 12.2.13. Roche Holding AG
    • 12.2.14. Sanofi S.A.
    • 12.2.15. Seattle Genetics, Inc.
    • 12.2.16. Takeda Pharmaceutical Company Limited
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us